erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the..
"the hospital — i don't know what to say. everyone was amazing," he said..
a sign at a planned parenthood clinic is pictured in oklahoma city, in 2015.